Publications 2025

Gjefsen E, Bråten LC, Ponzi E, Dagestad MH, Marchand GH, Kadar T, Bakland G, Haugen AJ, Granviken F, Flørenes TW, Vetti N, Grøvle L, Nilsen AT, Lunestad A, Holmgard TE, Valberg M, Bolstad N, Espeland A, Brox JI, Goll GL, Storheim K, Zwart JA (2025)
Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low-Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial
77 (5), 615-623
DOI 10.1002/art.43073, PubMed 39624017

Perrier F, Ahimbisibwe A, Ghiasvand R, Rueegg CS, Green AC, Borch KB, Braaten T, Weiderpass E, Valberg M, Robsahm TE, Veierød MB (2025)
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)
157 (5), 846-857
DOI 10.1002/ijc.35430, PubMed 40181554

Publications 2024

Eick F, Vallersnes OM, Fjeld HE, Sørbye IK, Valberg M, Dahl C (2024)
Perinatal mortality among pregnant undocumented migrants in Norway 1999-2020: A register-based population study
353, 117055
DOI 10.1016/j.socscimed.2024.117055, PubMed 38897075

Nguyen HT, Moger TA, Valberg M, Degerud E, Page CM, LeBlanc M, Næss Ø (2024)
Individual heterogeneity, educational attainment and cardiovascular mortality: a pooled analysis of Norwegian health surveys
2 (2), e000104
DOI 10.1136/bmjph-2023-000104, PubMed 40018537

Publications 2023

Ahimbisibwe A, Valberg M, Green AC, Ghiasvand R, Rueegg CS, Rimal R, Weiderpass E, Sandanger TM, Robsahm TE, Veierød MB (2023)
Nevus Count, Pigmentary Characteristics, and Melanoma-specific Mortality among Norwegian Women with Melanoma >1.0 mm Thick
103, adv4403
DOI 10.2340/actadv.v103.4403, PubMed 37014267

Brathovde M, Moger TA, Aalen OO, Grotmol T, Veierød MB, Valberg M (2023)
A lean additive frailty model: With an application to clustering of melanoma in Norwegian families
42 (23), 4207-4235
DOI 10.1002/sim.9856, PubMed 37527835

Choi HJ, LeBlanc M, Moger TA, Valberg M, Page CM, Aamodt G, Næss Ø (2023)
Geographical variation in cardiovascular disease mortality in Norway: The role of life course socioeconomic position and parental health
83, 103095
DOI 10.1016/j.healthplace.2023.103095, PubMed 37659155

Methi F, Gran JM, Valberg M, Kinge JM, Telle K, Magnusson K (2023)
Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care: a matched cohort study
21 (1), 157
DOI 10.1186/s12916-023-02870-2, PubMed 37101263

Publications 2022

Choi HJ, LeBlanc M, Moger TA, Valberg M, Aamodt G, Page CM, Tell GS, Næss Ø (2022)
Stroke survival and the impact of geographic proximity to family members: A population-based cohort study
309, 115252
DOI 10.1016/j.socscimed.2022.115252, PubMed 35988529

Hagemo JS, Skulberg AK, Rehn M, Valberg M, Pesonen M, Heimdal HJ, Heyerdahl F (2022)
Inhaled nitric oxide as temporary respiratory stabilization in patients with COVID-19 related respiratory failure (INOCOV): Study protocol for a randomized controlled trial
17 (5), e0268822
DOI 10.1371/journal.pone.0268822, PubMed 35622848

Myhrvold SB, Brouwer EF, Andresen TKM, Rydevik K, Amundsen M, Grün W, Butt F, Valberg M, Ulstein S, Hoelsbrekken SE (2022)
Nonoperative or Surgical Treatment of Acute Achilles' Tendon Rupture
386 (15), 1409-1420
DOI 10.1056/NEJMoa2108447, PubMed 35417636

Skulberg AK, Tylleskär I, Valberg M, Braarud AC, Dale J, Heyerdahl F, Skålhegg T, Barstein J, Mellesmo S, Dale O (2022)
Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial
117 (6), 1658-1667
DOI 10.1111/add.15806, PubMed 35137493

Valberg M, Gran JM, Rueegg CS, LeBlanc M (2022)
Letter to the editor regarding "Covid-19 transmission in fitness centers in Norway - a randomized trial"
22 (1), 2433
DOI 10.1186/s12889-022-14800-7, PubMed 36575451

Publications 2020

Gjefsen E, Bråten LCH, Goll GL, Wigemyr M, Bolstad N, Valberg M, Schistad EI, Marchand GH, Granviken F, Selmer KK, Froholdt A, Haugen AJ, Dagestad MH, Vetti N, Bakland G, Lie BA, Haavardsholm EA, Nilsen AT, Holmgard TE, Kadar TI, Kvien T, Skouen JS, Grøvle L, Brox JI, Espeland A et al. (2020)
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial
21 (1), 698
DOI 10.1186/s12891-020-03720-5, PubMed 33087100

Skulberg AK, Tylleskär I, Braarud AC, Dale J, Heyerdahl F, Mellesmo S, Valberg M, Dale O (2020)
NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use
10 (11), e041556
DOI 10.1136/bmjopen-2020-041556, PubMed 33184084

Publications 2019

Stensrud MJ, Aalen JM, Aalen OO, Valberg M (2019)
Limitations of hazard ratios in clinical trials
40 (17), 1378-1383
DOI 10.1093/eurheartj/ehy770, PubMed 30500891

Publications 2018

Bugge AS, Lund MB, Valberg M, Brustugun OT, Solberg S, Kongerud J (2018)
Cause-specific death after surgical resection for early-stage non-small-cell lung cancer
53 (1), 221-227
DOI 10.1093/ejcts/ezx274, PubMed 28950311

Mohn CH, Blix HS, Halvorsen JA, Nafstad P, Valberg M, Lagerløv P (2018)
Incidence Trends of Atopic Dermatitis in Infancy and Early Childhood in a Nationwide Prescription Registry Study in Norway
1 (7), e184145
DOI 10.1001/jamanetworkopen.2018.4145, PubMed 30646341

Valberg M, Stensrud MJ, Aalen OO (2018)
The surprising implications of familial association in disease risk
18 (1), 135
DOI 10.1186/s12889-018-5033-5, PubMed 29334951

Publications 2017

Stensrud MJ, Strohmaier S, Valberg M, Aalen OO (2017)
Can chance cause cancer? A causal consideration
75, 83-85
DOI 10.1016/j.ejca.2016.12.022, PubMed 28219021

Stensrud MJ, Valberg M (2017)
Inequality in genetic cancer risk suggests bad genes rather than bad luck
8 (1), 1165
DOI 10.1038/s41467-017-01284-y, PubMed 29079851

Stensrud MJ, Valberg M, Røysland K, Aalen OO (2017)
Exploring Selection Bias by Causal Frailty Models: The Magnitude Matters
28 (3), 379-386
DOI 10.1097/EDE.0000000000000621, PubMed 28244888

Stensrud MJ, Valberg M, Aalen OO (2017)
Can Collider Bias Explain Paradoxical Associations?
28 (4), e39-e40
DOI 10.1097/EDE.0000000000000653, PubMed 28575895

Publications 2016

Rancoita PM, Valberg M, Demicheli R, Biganzoli E, Di Serio C (2016)
Tumor dormancy and frailty models: A novel approach
73 (1), 260-270
DOI 10.1111/biom.12559, PubMed 27398936

Valberg M, Grotmol T, Tretli S, Veierød MB, Moger TA, Devesa SS, Aalen OO (2016)
Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
32 (6), 511-520
DOI 10.1007/s10654-016-0185-z, PubMed 27431530

Publications 2015

Aalen OO, Valberg M, Grotmol T, Tretli S (2015)
Authors' response: Understanding variation in disease risk
44 (4), 1426-8
DOI 10.1093/ije/dyv047, PubMed 25842265

Publications 2014

Aalen OO, Valberg M, Grotmol T, Tretli S (2014)
Understanding variation in disease risk: the elusive concept of frailty
44 (4), 1408-21
DOI 10.1093/ije/dyu192, PubMed 25501685

Publications 2013

Valberg M, Grotmol T, Tretli S, Veierød MB, Moger TA, Aalen OO (2013)
A hierarchical frailty model for familial testicular germ-cell tumors
179 (4), 499-506
DOI 10.1093/aje/kwt267, PubMed 24219863

Publications 2012

Valberg M, Grotmol T, Tretli S, Veierød MB, Devesa SS, Aalen OO (2012)
Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 years
31 (28), 3731-47
DOI 10.1002/sim.5441, PubMed 22744906